Cancer BiologybioRxiv
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.
Y. Wee, J. Wang, E. C. Wilson…·A. H. Grossmann
This study identifies ARF6-dependent endocytic trafficking of the IFN-gamma receptor as a mechanism driving adaptive immune resistance in cancer, linking it to immune checkpoint blockade efficacy.
DOI 10.1038/s41467-024-50881-1